Novartis will shutter two Asian research facilities, but says Shanghai's position as third R&D hub alongside Basel and Cambridge is secure.

If Hilleman Labs is successful in scouting for a rotavirus vaccine partnership, India might see a new force added to its efforts to fight child and infant…

Sun Pharmaceutical Industries has taken the lead in a fiercely contested race to market with Johnson & Johnson for a new class of psoriasis drug.

Hanmi Pharma gained one big deal with Roche this week but lost another tie-up with Boehringer--and investors didn't like it one bit.

Complicated drug formulations are generally viewed as a barrier to generic competition, but that is not stopping India's Glenmark from placing Celgene…

With India in the throes of an outbreak of Chikungunya, local drugmaker Zydus Cadila has stepped up to develop a vaccine against the crippling viral disease--…

Japan's Otsuka is hoping that smart packaging could help one of its main pharma products maintain a hold in the marketplace.

Hepatitis C is a big problem in China, and drugmakers are still waiting on approval for their next-gen treatments. Now, regulators are promising action--and…

Government warns drugmakers could leave the UK if the country's separation from the EU drags on and is kept under wraps.

R&D